Max Kepler, a former outfielder for the Philadelphia Phillies, has recently been designated for assignment by the Arizona Diamondbacks, marking a swift end to his attempt at a major league comeback. Kepler’s troubles began after receiving an 80-game suspension for testing positive for performance-enhancing drugs (PEDs), a setback that complicated his free agency following a disappointing 2025 season with the Phillies. During that year, he hit .216/.300/.391 with 18 home runs and an 88 wRC+, numbers that failed to secure him a long-term role with Philadelphia.

After serving most of his suspension, Kepler signed a prorated contract with the Diamondbacks midseason in June 2026, hoping to revive his career. However, his return to the field did not meet expectations, as he posted a .205/.262/.303 slash line with just two home runs over 145 plate appearances. His production, including a career-low isolated power mark of .098, was especially weak against right-handed pitchers, an area where he had previously found more success. These struggles came as Arizona was pushing for a playoff spot, prompting the team to replace him by recalling catcher Adrian Del Castillo from Triple-A Reno.

Kepler recently addressed his PED suspension publicly for the first time, offering a controversial explanation that his positive test might have resulted from consuming contaminated red meat. Although he and his legal team explored this theory, he acknowledged its weakness, noting that it would be unlikely for any meat supplier to admit contamination. Despite his defense, the positive test remains on his record, and the performance gap before and after the suspension has fueled skepticism among observers who note his decline after returning to play.

The 33-year-old veteran’s career now hangs in the balance, with his future uncertain after the Diamondbacks cut ties amid underwhelming results. Kepler’s brief tenure with his new team highlighted ongoing challenges in re-establishing his value in MLB following his suspension and diminished offensive output. As teams weigh performance and character concerns, Kepler’s next opportunity, if any, remains to be seen in the evolving landscape of professional baseball.